Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Molecular and Cellular Biology

• Publication date

  2003-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.23.23.8691-8703.2003PMID 14612410PMCID PMC262670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autocrine Transforming Growth Factor-β Signaling Mediates Smad-independent Motility in Human Cancer Cells*

  2003cited by this paper
• Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.

  2002cited by this paper
• Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis

  2002cited by this paper
• Missing pieces in the NF-kappaB puzzle.

  2002cited by this paper
• TGF-beta signaling: positive and negative effects on tumorigenesis.

  2002cited by this paper
• Metastasis is driven by sequential elevation of H-ras and Smad2 levels

  2002cited by this paper
• Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

  2002cited by this paper
• TGF-β signaling: positive and negative effects on tumorigenesis

  2002cited by this paper
• p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration.

  2002influential reference
• ErbB2/Neu-Induced, Cyclin D1-Dependent Transformation Is Accelerated in p27-Haploinsufficient Mammary Epithelial Cells but Impaired in p27-Null Cells

  2002cited by this paper
• Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases

  2002cited by this paper
• The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini.

  2002cited by this paper
• Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Genomics, the cytoskeleton and motility

  2001cited by this paper
• Cyclin-Dependent Kinase Inhibitor P27Kip1 Is Required for Mouse Mammary Gland Morphogenesis and Function

  2001influential reference
• Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1.

  2001cited by this paper
• Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.

  2001cited by this paper
• ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini

  2001cited by this paper
• Apoptosis in Ductal Carcinoma in Situ of the Breast

  2001cited by this paper
• TGF-beta signaling in tumor suppression and cancer progression.

  2001cited by this paper
• Controlling TGF-β signaling

  2000cited by this paper
• Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas

  2000cited by this paper
• Transforming growth factor-β and breast cancer: Tumor promoting effects of transforming growth factor-β

  2000cited by this paper
• A critical step in metastasis: in vivo analysis of intravasation at the primary tumor.

  2000cited by this paper
• Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells.

  2000cited by this paper
• Role of transforming growth factor-beta signaling in cancer.

  2000cited by this paper
• Controlling TGF-beta signaling.

  2000cited by this paper
• The ErbB signaling network: receptor heterodimerization in development and cancer

  2000cited by this paper
• Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.

  2000cited by this paper
• The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins.

  2000cited by this paper
• Role of Transforming Growth Factor-β Signaling in Cancer

  2000cited by this paper
• NF-κB is a target of AKT in anti-apoptotic PDGF signalling

  1999cited by this paper
• Transforming Growth Factor-β and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia.

  1999cited by this paper
• Signaling to Rho GTPases.

  1999cited by this paper
• NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.

  1999cited by this paper
• NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase

  1999cited by this paper
• Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia.

  1999cited by this paper
• Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.

  1998cited by this paper
• Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene

  1998cited by this paper
• Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.

  1998cited by this paper
• TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.

  1998cited by this paper
• Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase*

  1998influential reference
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity.

  1997cited by this paper
• Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.

  1997cited by this paper
• Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated Signaling*

  1997cited by this paper
• Transgenic Mice Overexpressing a Dominant-negative Mutant Type II Transforming Growth Factor β Receptor Show Enhanced Tumorigenesis in the Mammary Gland and Lung in Response to the Carcinogen 7,12-Dimethylbenz-[a]-anthracene

  1997cited by this paper
• TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.

  1996cited by this paper
• Extracellular Signal-regulated Kinase and the Small GTP-binding Protein, Rac, Contribute to the Effects of Transforming Growth Factor-β1 on Gene Expression*

  1996cited by this paper
• Mammary tumor suppression by transforming growth factor beta 1 transgene expression.

  1995cited by this paper
• Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population.

  1995cited by this paper
• Rho Family GTPases Regulate p38 Mitogen-activated Protein Kinase through the Downstream Mediator Pak1 (*)

  1995cited by this paper
• Mechanism of activation of the TGF-β receptor

  1994cited by this paper
• Mechanism of activation of the TGF-beta receptor.

  1994cited by this paper
• Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.

  1993cited by this paper
• Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

  1992influential reference
• Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development.

  1991cited by this paper
• The transforming growth factor-beta family.

  1990cited by this paper
• Growth modulation of mouse keratinocytes by transforming growth factors.

  1988cited by this paper
• Integrin (cid:1) 1 Signaling Is Necessary for Transforming Growth Factor- (cid:1) Activation of p38MAPK and Epithelial Plasticity*

  year unknowncited by this paper
• Transforming Growth Factor (cid:1) Enhances Epithelial Cell Survival via Akt-dependent Regulation of FKHRL1

  year unknowncited by this paper

• Phytochemicals Alleviate Tumorigenesis by Regulation of M1/M2 Polarization: A Systematic Review of the Current Evidence

  2025cites this paper
• Cytokine Networks in Triple-Negative Breast Cancer: Mechanisms, Therapeutic Targets, and Emerging Strategies

  2025cites this paper
• Large-Scale Characterization of Orthotopic Cell Line-Derived Xenografts Identifies TGF-β Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness.

  2025cites this paper
• TGF-β1 and FOXM1 siRNA co-loaded nanoparticles by disulfide crosslinked PEG-PDMAEMA for the treatment of triple-negative breast cancer and its bone metastases in vitro

  2024cites this paper
• Crosstalk between TGF-β and EGF receptors via direct phosphorylation

  2024cites this paper
• HER2 phosphorylation induced by TGF-β promotes mammary morphogenesis and breast cancer progression

  2024cites this paper
• C1orf106 (INAVA) Is a SMAD3-Dependent TGF-β Target Gene That Promotes Clonogenicity and Correlates with Poor Prognosis in Breast Cancer

  2024cites this paper
• CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis.

  2023cites this paper
• The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β

  2022cites this paper
• Prognostic significance of transforming growth factor β receptor II in clinical stage III breast cancer patients - a pilot study

  2021cites this paper
• TGFβ1 in Cancer-Associated Fibroblasts Is Associated With Progression and Radiosensitivity in Small-Cell Lung Cancer

  2021cites this paper
• Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis

  2021cites this paper
• Properties and gene expression profiling of acquired radioresistance in mouse breast cancer cells

  2021cites this paper
• Autocrine TGF-β in Cancer: Review of the Literature and Caveats in Experimental Analysis

  2021cites this paper
• The TGFβ and Androgen Receptor Signaling Pathways Converge to Support Anoikis Resistance in Triple Negative Breast Cancer

  2021cites this paper
• The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation

  2020cites this paper
• Aging-Associated Alterations in Mammary Epithelia and Stroma Revealed by Single-Cell RNA Sequencing

  2020cites this paper
• Heterogeneity of luminal A and HER2-positive breast cancer based on DIA quantitative proteomics and bioinformatics analysis techniques

  2020cites this paper
• Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.

  2020cites this paper
• 3,3′-Diindolylmethane Inhibits TNF-α- and TGF-β-Induced Epithelial–Mesenchymal Transition in Breast Cancer Cells

  2019cites this paper
• Stromal fibroblasts induce metastatic tumor cell clusters via epithelial–mesenchymal plasticity

  2019cites this paper
• Molecular and Transcriptional Signatures for ErbB2-Induced Invasion

  2018cites this paper
• Characterisation of targeted imaging and theranostic agents for cancer and fibrosis

  2018cites this paper
• TGF-&bgr; signaling in cancer

  2018cites this paper
• Oncogenic activity of poly (ADP-ribose) glycohydrolase

  2018cites this paper
• HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.

  2018cites this paper
• Inflammatory Role of Cancer-Associated Fibroblasts in Invasive Breast Tumors Revealed Using a Fibrous Polymer Scaffold.

  2018cites this paper
• Interplay between TGF-β signaling and receptor tyrosine kinases in tumor development

  2017cites this paper
• TGF-β signaling regulation in breast cancer metastasis

  2017cites this paper
• Emerging roles for LPP in metastatic cancer progression

  2017cites this paper
• The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ

  2017cites this paper
• Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis

  2017cites this paper
• HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance

  2017influential citation
• Role of transforming growth factor-β1 in triple negative breast cancer patients.

  2017cites this paper
• TGF- b Family Signaling in Tumor Suppression and Cancer Progression

  2017cites this paper
• The crossroads of breast cancer progression: insights into the modulation of major signaling pathways

  2017cites this paper
• TGF-β Family Signaling in Tumor Suppression and Cancer Progression.

  2017cites this paper
• Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion

  2016cites this paper
• Methods to Study Metastasis in Genetically Modified Mice.

  2016cites this paper
• Hormone-Sensing Mammary Epithelial Progenitors: Emerging Identity and Hormonal Regulation

  2015cites this paper
• Bisdemethoxycurcumin (BDMC) Alters Gene Expression-associated Cell Cycle, Cell Migration and Invasion and Tumor Progression in Human Lung Cancer NCI-H460 Cells.

  2015cites this paper
• Perioperative propofol-paravertebral anesthesia decreases the metastasis and progression of breast cancer

  2015cites this paper
• The relevance of EMT in breast cancer metastasis: Correlation or causality?

  2015cites this paper
• Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.

  2015cites this paper
• Breast cancer cells respond differentially to modulation of TGFβ2 signaling after exposure to chemotherapy or hypoxia.

  2015cites this paper
• Cytokine-macrophage regulatory network in mammary gland development and tumourigenesis

  2015cites this paper
• Drug Discovery Today : Disease Models

  2015cites this paper
• Mechanisms of action and resistance to anti-angiogenic small-molecule tyrosine kinase inhibitors in preclinical breast cancer and pancreatic neuroendocrine tumor mouse models

  2015cites this paper
• Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development

  2015cites this paper
• Characterization of the Stromal and Epithelial Pathways in the Mammary Gland causing Susceptibility to Cancer

  2015cites this paper
• Rôle de ADAM12 dans la Transition Epithélio-Mésenchymateuse

  2015cites this paper
• Étude sur les fonctions in vivo des GEFs DOCK chez les mammifères

  2014cites this paper
• When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase

  2014cites this paper
• Altered Transcriptional Control Networks with Trans-Differentiation of Isogenic Mutant-KRas NSCLC Models

  2014influential citation
• Inducing an Epithelial to Mesenchymal Transition

  2014cites this paper
• Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis

  2014cites this paper
• Metastatic heterogeneity of breast cancer cells is associated with expression of a heterogeneous TGFβ-activating miR424-503 gene cluster.

  2014cites this paper
• The atypical chemokine receptor CCX‐CKR regulates metastasis of mammary carcinoma via an effect on EMT

  2014cites this paper
• Cluster 503 Gene −-Activating miR 424 β Expression of a Heterogeneous TGF Metastatic Heterogeneity of Breast Cancer Cells Is Associated with

  2014cites this paper
• Régulation de l’activité transcriptionnelle des récepteurs des estrogènes (ER) par le récepteur à chimiokine CXCR4 et les récepteurs à activité tyrosine kinase ErbB2 et ErbB3

  2014cites this paper
• Investigating the Role of Retinoblastoma Protein and Transforming Growth Factor-Beta in Growth Inhibition

  2014cites this paper
• p66ShcA Promotes Breast Cancer Plasticity by Inducing an Epithelial-to-Mesenchymal Transition

  2014cites this paper
• Title The Functional Crosstalk between HER 2 Tyrosine Kinase and TGF-β Signaling in Breast Cancer Malignancy

  2014cites this paper
• Cytokine Networks That Mediate Epithelial Cell-Macrophage Crosstalk in the Mammary Gland: Implications for Development and Cancer

  2014cites this paper
• TGF-β: duality of function between tumor prevention and carcinogenesis.

  2014cites this paper
• Therapeutic Targeting of Integrin αvβ6 in Breast Cancer

  2014cites this paper
• TGF-β as Tumor Suppressor: Lessons from Mouse Models

  2013cites this paper
• Role of TGF-β in breast cancer bone metastases

  2013cites this paper
• TGF-β in Human Disease

  2013cites this paper
• Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells.

  2013cites this paper
• Award Number: W81XWH-10-1-0256 TITLE: Role of VAPB-MSP, a Novel EphA2 RTK Antagonist in Breast Cancer

  2013influential citation
• Cucurbitacin I Inhibits Rac 1 Activation in Breast Cancer Cells by a Reactive Oxygen Species-Mediated Mechanism and Independently of Janus Tyrosine Kinase 2 and P-Rex 1 s

  2013cites this paper
• Rebuilding cancer metastasis in the mouse

  2013cites this paper
• Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients.

  2013cites this paper
• Prospective dual role of mesenchymal stem cells in breast tumor

  2013cites this paper
• A complex containing LPP and &agr;-actinin mediates TGF&bgr;-induced migration and invasion of ErbB2-expressing breast cancer cells

  2013cites this paper
• Cucurbitacin I Inhibits Rac1 Activation in Breast Cancer Cells by a Reactive Oxygen Species-Mediated Mechanism and Independently of Janus Tyrosine Kinase 2 and P-Rex1

  2013cites this paper
• Rekombinantní vakcíny proti solidním a hematologickým nádorům: vývoj a stanovení jejich účinnosti

  2013cites this paper
• Targeting Pro-Angiogenic TGF-β Signaling in the Tumor Microenvironment

  2013cites this paper
• Co-evolution of breast-to-brain metastasis and neural progenitor cells

  2013cites this paper
• Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.

  2012cites this paper
• Pharmacological strategies to overcome HER2 cross-talk and Trastuzumab resistance.

  2012cites this paper
• Complexities of TGF-β Targeted Cancer Therapy

  2012cites this paper
• VAMP-Associated Protein B (VAPB) Promotes Breast Tumor Growth by Modulation of Akt Activity

  2012cites this paper
• Absence of TGF-βRII predicts bone and lung metastasis and is associated with poor prognosis in stage III breast tumors

  2012cites this paper
• Processing Confers a Novel Function in RNA Receptor β Transforming Growth Factor Nuclear Translocation of Type

  2012cites this paper
• Nuclear Translocation of Type I Transforming Growth Factor β Receptor Confers a Novel Function in RNA Processing

  2012cites this paper
• Prospective dual role of mesenchymal stem cells in breast tumor microenvironment

  2012cites this paper
• TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer

  2012cites this paper
• Molecular Pathways Molecular Pathways : Targeting the TGF-b Pathway for Cancer Therapy

  2012cites this paper
• Regulation of EMT by TGFβ in cancer

  2012cites this paper
• Modeling Transforming Growth Factor-ß Signaling in Cancer

  2012cites this paper
• Matrix rigidity regulates a switch between TGF-β1–induced apoptosis and epithelial–mesenchymal transition

  2012cites this paper
• LPP is Required for TGF-Beta Induced Motility and Invasion of Neu/ErbB-2 Expressing Breast Cancer Cells

  2012cites this paper
• Seed, soil and secreted hormones: potential interactions of breast cancer cells with their endocrine/paracrine microenvironment and implications for treatment with bisphosphonates.

  2012cites this paper
• Molecular and Cellular Pathobiology Angiocrine Factors Modulate Tumor Proliferation and Motility through EphA 2 Repression of Slit 2 Tumor Suppressor Function in Endothelium

  2011cites this paper
• Expression of soluble TGF-β receptor II by recombinant Vaccinia virus enhances E7 specific immunotherapy of HPV16 tumors.

  2011cites this paper
• Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium.

  2011cites this paper
• Hunk is required for HER2/neu-induced mammary tumorigenesis.

  2011cites this paper
• Relation between transforming growth factor-β1 expression, its receptor and clinicopathological factors and survival in HER2-negative gastric cancers

  2011cites this paper